| Labatec Pharma SA - Fulvestrant Labatec 250 mg/5 ml, Solution pour injection en seringue pré-remplie |
| 68761 | | 01 | | Fulvestrant Labatec 250 mg/5 ml | | Solution pour injection en seringue pré-remplie | | L02BA03 | | Fulvestrant | | 22.11.2022 | | |
|
| Composition |
| fulvestrantum 250 mg, ethanolum 96 per centum 500 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ricini oleum raffinatum q.s. ad solutionem pro 5 ml corresp. ethanolum 12 % V/V. |
| Packungsbestandteile |
| Solution pour injection en seringue pré-remplie | | | | | | Active Agent | Dose |
|---|
| Fulvestrant | 250mg / 5ml |
| | | | Inactive agents | Dose |
|---|
| Alcohol Benzylicus | 500mg / 5ml | | Benzyl Benzoate | 750mg / 5ml | | Ethanolum 96 Per Centum | 500mg / 5ml | | Ricini Oleum Raffinate | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 2 | PR | PR | B | | Yes |
|
